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Abstract
AIM: To assess the role of Helicobacter pylori  (H. pylori ), 
gastroesophageal reflux disease (GERD), age, smok-
ing and body weight on the development of intestinal 
metaplasia of the gastric cardia (IMC). 
METHODS: Two hundred and seventeen patients sched-
uled for esophagogastroduodenoscopy were enrolled 
in this study. Endoscopic biopsies from the esophagus, 
gastroesophageal junction and stomach were evaluated 
for inflammation, the presence of H. pylori  and intesti-
nal metaplasia. The correlation of these factors with the 
presence of IMC was assessed using logistic regression.
RESULTS: IMC was observed in 42% of the patients. 
Patient age, smoking habit and body mass index (BMI) 
were found as potential contributors to IMC. The risk of 
developing IMC can be predicted in theory by combining 
these factors according to the following formula: Risk of 
IMC = a + s - 2B where a = 2,…6 decade of age, s = 0 
for non-smokers or ex-smokers, 1 for < 10 cigarettes/d, 
2 for > 10 cigarettes/d and B = 0 for BMI < 25 kg/m2 
(BMI < 27 kg/m2 in females), 1 for BMI > 25 kg/m2 (BMI 
> 27 kg/m2 in females). Among potential factors asso-
ciated with IMC, H. pylori  had borderline significance (P 
= 0.07), while GERD showed no significance.
CONCLUSION: Age, smoking and BMI are potential 
factors associated with IMC, while H. pylori  and GERD 
show no significant association. IMC can be predicted 
in theory by logistic regression analysis.
© 2012 Baishideng. All rights reserved.
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INTRODUCTION
The development of  gastric cancer involves an interplay of  
bacterial, host, and environmental facts, including dietary 
factors, lifestyle factors and Helicobacter pylori (H. pylori)[1-3]. 
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The worldwide incidence of  gastric cancer has declined 
over the recent decades[4]. Part of  this decline is due to the 
recognition of  risk factors such as H. pylori infection and 
other environmental risk factors[3,5]. Despite the overall de-
cline in gastric cancer, there has been a significant increase 
in the incidence of  cancer of  the gastric cardia[6]. The shift 
from distal to proximal stomach may be due to the de-
crease in the distal cancers. 
However, it has also been proposed that adenocarci-
nomas at the cardia represent a different entity of  antral 
gastric adenocarcinomas[7]. Indeed, environmental factors 
or chemical carcinogens may be more strongly associated 
with cardia carcinomas compared with more distal gastric 
carcinoma[8]. On the other hand, the proximal gastric car-
cinomas differ from distal gastric carcinomas as they are 
not associated with a severe form of  gastritis character-
ized by atrophy and/or intestinal metaplasia[9,10].
Carcinomas of  the gastric cardia appear to be similar 
to those associated with Barrett’s esophagus, with which 
they share some demographic features[9]. Several studies 
indicated that obesity satisfies several criteria for a causal 
association with gastroesophageal reflux disease (GERD) 
and some of  its complications, including erosive esopha-
gitis, and esophageal adenocarcinoma[11-13]. Therefore, 
obesity could represent an important factor in the devel-
opment of  cardia carcinoma.
The development of  cardia carcinoma seems to be 
preceded by intestinal metaplasia, which is secondary to 
chronic inflammation[1,14-16]. However, the etiology of  
intestinal metaplasia of  the gastric cardia (IMC) remains 
controversial. To our knowledge, no study has evaluated 
the effects of  age, smoking and body weight on IMC. 
Thus, our aim was to set up a cross-sectional study to 
examine these the role of  these factors, and also H. pylori 
and GERD. To evaluate the incidence of  IMC and the 
respective role of  these factors on the development of  
IMC at a particular point in time, we enrolled a popula-
tion of  outpatients with upper gastrointestinal (GI) en-
doscopy scheduled for various reasons. 
MATERIALS AND METHODS
Study design and population
The study complied with the Declaration of  Helsinki 
regarding investigation in humans and was approved 
by our institutional Ethics committee (Commission 
Centrale d’Ethique) (Controlled-trials.com, Number IS-
RCTN15324190, www.con trolled-trials.com). This was 
an investigator-initiated study with no involvement of  
industry.
Inclusion criteria
All outpatients scheduled for an elective upper GI endos-
copy were eligible for inclusion in the study. Exclusion 
criteria were: age < 18 years, pregnancy, patients unable 
to give their own consent, a previous history of  upper 
GI surgery, severe bleeding diathesis (platelet count < 
50 000/mm3, prothrombin rate < 50%), psychiatric dis-
eases, allergy to lidocaine. All patients signed an informed 
consent form.
For this study, 250 consecutive patients scheduled for 
upper GI endoscopy for a variety of  conditions were re-
cruited over a 2.5-year period. Among them, 217 accept-
ed the study protocol (acceptance rate of  86%). Endos-
copy was performed in the left lateral position after local 
anesthesia using a 10% xylocaine spray with the patient 
under conscious sedation using midazolam as reported 
previously[17]. A standard endoscopy was performed, in-
cluding retroflexion in the stomach (Table 1).
Endoscopic biopsies 
Each patient had 2 biopsies performed in the esophagus 
2 cm above the Z-line, 4 biopsies at the esophagogastric 
junction, 2 biopsies in the cardia located within 10 mm 
below the Z-line, 2 biopsies in the fundus (greater and 
lesser curvature), 2 biopsies in the antrum (greater and 
lesser curvature), and one biopsy in the angulus. In the 
case of  Barrett’s esophagus, 4 biopsies were performed 
every cm in the Barrett’s segment. All biopsy specimens 
were fixed in 0.5% formaldehyde solution and stained 
with haematoxylin eosin, Giemsa, and Gomori-aldehyde-
fuschin. Two experienced GI pathologists (BH, MB), 
who were blinded to the clinical diagnosis, analyzed the 
biopsies. The diagnosis of  IMC was reserved for patients 
with intestinal metaplasia detected in biopsy specimens 
sampled from the macroscopically normal-appearing gas-
troesophageal junction.
Study variables and data collection
As previously defined by Vakil et al[18], clinically significant 
GERD was diagnosed when reflux of  the gastric con-
tents caused troublesome symptoms and/or complica-
tions. It was considered negative if  there were no such 
symptoms (Score 0), positive if  the patient presented 
symptoms once a month (Score 1) or more than once a 
month (Score 2). 
The presence of  a hiatus hernia was defined as wid-
ening of  the muscular hiatal tunnel and circumferential 
laxity of  the phrenoesophageal membrane[19], allowing a 
portion of  the stomach to slide into the thorax. 
Smoking habit (never smoking: score 0; past smoker: 
score 1; current smoker < 1 pack per day: score 2; cur-
rent smoker > 1 pack per day: score 3), body mass index 
(BMI) and age were recorded. 
Endoscopic biopsies from the esophagus, the Z-line, 
the cardia, the fundus and the antrum were histologically 
evaluated for the following criteria: (1) Acute and chronic 
inflammation using a visual analogue scale from 0 to 3 as 
proposed by Dixon et al[20] in an updated Sydney system, 
0 being none and 3 being marked; (2) Absence or pres-
ence of  incomplete (types Ⅰ, Ⅱ) or complete (type Ⅲ) 
intestinal metaplasia as defined by Filipe et al[21]; and (3) 
Absence or presence of  H. pylori.
Barrett’s esophagus was defined as “a change in the 
distal esophageal epithelium of  any length that can be 
recognized as metaplastic mucosa at endoscopy and con-
firmed to have intestinal metaplasia by biopsy of  the tubu-
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lar esophagus”[22]. Short segment Barrett’s esophagus was 
considered if  metaplasia extended < 3 cm into the tubular 
esophagus or long segment Barrett’s esophagus if  metapla-
sia extended > 3 cm into the tubular esophagus. Patients 
taking nonsteroidal anti-inflammatory drugs and/or proton 
pump inhibitors (PPI) during the last month before inclu-
sion and continuously for more than 6 mo were defined as 
regular non steroidal antiinflammatory drug or PPI users.
Statistical analysis
The analysis of  group variables was studied primarily using 
cross-tabulation analysis (Fischer’s exact test). The Kruskal-
Wallis test was used to test equality of  the population. Mul-
tivariate analysis of  predictors of  IMC was performed by 
linear logistic regression. To accomplish this goal, a model 
was created that included all predictor variables. Multiple 
logistic regression analysis was used to develop an equa-
tion to predict a logit transformation of  the probability of  
IMC based on risk factors that included in the equation: age 
(years), BMI (kg/m2), smoking habit, sex, reflux disease and 
hiatal hernia. Age and BMI, were modeled as continuous 
variables, and sex was modeled as a categorical variable (0 = 
male and 1 = female). The final mathematical equation pro-
vided an estimate of  a subject’s likelihood of  having IMC. 
P values < 0.05 were interpreted as statistically significant. 
P values > 0.05 were taken as non significant (NS). SPSS 
advanced models 10.0 was used for statistical analysis. 
RESULTS
A total of  217 patients were enrolled in the current study. 
Table 1 presents the characteristics of  the group accord-
ing to the sex distribution. There were no significant dif-
ferences among the two groups except a higher frequency 
of  Barrett’s esophagus in men and a higher rate of  gastric 
bypass in women. BMI exceeded 25 kg/m2 in 54 males 
(56%) and 27 kg/m2 in 61 females (51%). Because our 
surgical team has a long lasting program of  bariatric sur-
gery[23], a substantial number of  patients evaluated for 
gastric bypass (22%) was included but the mean BMI 
in the overall cohort was < 30 kg/m2. Epigastric pain 
and gastroesophageal reflux were the major causes for 
endoscopy. Of  note, almost half  of  the patients was tak-
ing a PPI and 45% of  the patients were past or current 
tobacco users. 
Endoscopy was normal in 36% of  the patients where-
as erosive esophagitis and hiatus hernia were the main 
endoscopic findings in our population (Table 2). Barrett’
s esophagus was histologically confirmed in 13% of  the 
patients. H. pylori was present in the gastric biopsies of  70 
patients (32%). 
We analyzed the potential relationship between 
the presence of  H. pylori and various factors including 
GERD, Barrett’s esophagus, hiatus hernia, tobacco use, 
sex and BMI (Table 3). There were statistically more pa-
tients infected by H. pylori with a normal esophagogastric 
junction (45%) than with long (16%) or short segment 
Barrett’s esophagus (11%) (P < 0.05). Patients with a hia-
tus hernia were less frequently infected by H. pylori than 
patients without (P < 0.05). Current tobacco users were 
more frequently infected by H. pylori than non or past 
smokers (P < 0.05). 
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Table 1  Characteristics of the cohort study group  n  (%)
Total Men Women P  value OR (95% CI)
No. of patients (%) 217 97 (45) 120 (55)
Age (yr) 45.3 ± 15.3 49.9 ± 16.5 43.3 ± 13.5
Reason for endoscopy1
   Epigastric pain   62 (29) 31 31 NS
   Barrett’s esophagus   26 (12) 20   6 0.01 4.94 (1.9-12.8)
   Reflux grade 1 17 (8)   6 11 NS
   Reflux grade 2 141 (65) 69 72 NS
   Dyspepsia   9 (4)   3   6 NS
   Dysphagia   2 (1)   2   0 NS
   Gastric bypass   48 (22)   7 41 0.01   0.15 (0.06-0.35)
   Anemia   5 (2)   2   3 NS
   Celiac disease suspicion   7 (3)   4   3 NS
   Ulcer follow-up   8 (4)   6   2 NS
   Helicobacter antibiogram   4 (2)   1   3 NS
Personal history of reflux 141 (65) 69 72 NS
Tobacco use
   Non smoker 119 (55) 46 73 NS
   Past smoker 11 (5)   5   6 NS
   Current smoker all   87 (40) 46 41 NS
   Current smoker 0.5 p/d   48 (22) 27 21 NS
   Current smoker > 1.0 p/d   39 (18) 19 20 NS
BMI 29.8 ± 10.6 32.4 ± 11.5 27.7 ± 7.7
PPI users   96 (44) 52 44 NS
NSAID users   37 (17) 20 17 NS
P value indicates results of the comparison of male and female patients. 1Patients may have more than one pathology. OR: Odds ratio; BMI: Body mass index; 
PPI: Proton pump inhibitor; NSAID: Non steroidal antiinflammatory drug; NS: Not significant.
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The correlation between the presence of  reflux symp-
toms, and Barrett’s esophagus, hiatus hernia, tobacco use, 
sex, age and BMI was shown in Table 4. All patients with 
short segment Barrett’s esophagus and 90% of  patients 
with long segment Barrett’s esophagus had significant 
reflux (P < 0.01). The presence of  reflux was not statisti-
cally significantly associated with the presence of  hiatus 
hernia or increased BMI. 
IMC was observed in 92 patients (42%), 48 were men 
and 44 were female, and the mean age was 27.3 years. 
IMC was not statistically associated (although there was 
a tendency) with the presence of  H. pylori (P > 0.05), 
whereas H. pylori was strongly associated with the pres-
ence of  inflammation of  the cardia (carditis) since 82% of  
patients infected with H. pylori had carditis compared with 
30% in the group without H. pylori infection (P < 0.001). 
Furthermore, there was a strong relationship between 
IMC and metaplasia found in other gastric areas, including 
the antrum and the corpus of  the stomach. This relation-
ship was not present in patients with Barrett’s esophagus. 
BMI was found to be significantly lower and age signifi-
cantly greater in patients with IMC than in patients with 
normal cardia mucosa. H. pylori played a pivotal role in the 
development of  metaplasia of  the antrum and the fundus, 
with an odds ratio reaching 7.4 and 11.2 respectively com-
pared with patients not infected with H. pylori (Table 5). 
GERD was not significantly associated with acute 
and chronic inflammation of  the gastroesophageal junc-
tion, and it was not associated with the presence of  IMC 
(borderline significance 0.06) (Table 5). Compared with 
patients with either short or long segment Barrett’s esoph-
agus, patients with IMC had significantly fewer GERD 
symptoms. 
In univariate analysis, age, BMI and tobacco use were 
statistically significantly associated with IMC (Table 5). 
Using logistic regression analysis, the presence of  IMC 
could be predicted by the patient’s age, smoking habit 
and the absence of  overweight according to the following 
formula: Risk score of  IMC = a + s - 2B where a = 2,…
6 decade of  age, s = 0 for non-smokers or ex-smokers, 1 
for < 10 cigarettes per day, 2 for > 10 cigarettes per day, 
and B = 0 for BMI < 25 kg/m2 (BMI < 27 kg/m2), 1 for 
BMI > 25 kg/m2 (BMI > 27 kg/m2) for males (females), 
respectively. In the presence of  these factors, H. pylori had 
only a borderline significance (P = 0.07) and would con-
tribute only 1 point on the above scale which ranges from 
0 to 8. Therefore, for a 50-year-old patient smoking 15 
cigarettes per day and with a BMI of  26 kg/m2, the theo-
retical risk of  having IMC is 5. The data of  82 patients 
with IMC were analyzed to obtain the actual frequency in 
percent of  IMC as a function of  the calculated risk score 
for a given patient using the above equation (Figure 1). 
Finally, the presence of  H. pylori was associated with se-
vere acute and chronic inflammation in the antrum (P < 
0.01), corpus (P < 0.01) and in the Z-line area (P < 0.01). 
DISCUSSION
During the last few decades there has been a marked in-
crease in the incidence of  adenocarcinoma of  the esopha-
gogastric junction in Western countries in contrast to 
the reduction in incidence of  distal gastric cancer. Most 
observers believe that this is the consequence of  an in-
creased rate of  adenocarcinoma of  the distal esophagus 
and a decreased incidence of  distal gastric cancer related 
to H. pylori eradication. If  the above-mentioned epidemio-
logic relationships are correct, this could indicate that the 
so-called cardia adenocarcinomas are not related to H. pylori 
infection but to other factors, and eventually may not be 
considered to be “gastric” cancers. 
Because of  the debated roles of  different clinical fac-
tors in the emergence of  malignant neoplasia of  the gas-
tric cardia, and because many reports have stated that IMC 
precedes the development of  cardiac cancer, our study was 
aimed at assessing the respective roles of  H. pylori, GERD, 
age, smoking habit and body weight on the develop-
ment of  IMC in a large group of  patients. To this end 
our cross-sectional study enrolled outpatients scheduled 
for upper GI endoscopy for various reasons and specifi-
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Table 2  Results of upper gastrointestinal endoscopy  n  (%)
Total Men Women P  value
No. of patients     217 97 120
Normal   79 (36) 43 36 NS
Esophagitis1   26 (12) 14 12 NS
Hiatus hernia1   60 (28) 36 24 NS
Short segment Barrett’s   9 (4)   6   3 NS
Long segment Barrett’s 19 (9) 11   8 NS
Esophageal tumor   4 (2)   3   1 NS
Gastric ulcer   4 (2)   3   1 NS
Gastric tumor      1 (0.5)   1   0 NS
Gastritis   9 (4)   5   4 NS
Duodenal ulcer   3 (1)   2   1 NS
Duodenal atrophy   2 (1)   1   1 NS
Other      1 (0.5)   1   0 NS
H. pylori
   Positive   70 (32) 33 37 NS
   Negative 147 (68) 64 83 NS
P value indicates results of the comparison of male and female patients. 
1Patients may have more than one pathology. NS: Not significant; H. pylori: 
Helicobacter pylori.
Figure 1  The curve indicates the actual risk (with standard deviation) of 
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cally searched for the presence of  IMC. The study then 
examined all the above mentioned variables to evaluate 
their respective role on the development of  IMC at a 
particular point in time. For this purpose, each patient 
had endoscopic gastric and esophageal biopsies. We paid 
specific attention to the cardia area because the location 
and extent of  the gastric cardia are controversial. Today, 
the vast majority of  the data available on the cardia and 
cardia cancer are not comparable because of  variations 
in the diagnostic criteria. Thus, to avoid any problem in 
“cardia” definition, we followed rigorous anatomist and 
endoscopist recommendations that defined the cardia as 
being the part of  the stomach that lies around the orifice 
of  the tubular esophagus, and which corresponds to the 
2080 May 7, 2012|Volume 18|Issue 17|WJG|www.wjgnet.com
Table 3  Relationship between the presence of Helicobacter pylori  and reflux, Barrett’s esophagus, hiatus hernia, tobacco, sex and 
body mass index  n  (%)
Total H. pylori  negative H. pylori  positive P  value OR (95% CI)
H. pylori             217                 147                 70
Reflux = 0   59 (27)   36 (61) 23 (39) NS
Reflux = 1 17 (8)   11 (65)   6 (35) NS
Reflux = 2 141 (65) 100 (71) 41 (29) NS
Short segment Barrett’s   9 (4)     8 (89)   1 (11) NS
Long segment Barrett’s 19 (9)   16 (84)   3 (16) NS
Normal gastroesophageal junction 189 (87) 122 (65) 67 (45) 0.01   4.58 (1.33-15.73)
Hiatus hernia
   Absent 157 (72) 100 (64) 57 (36) 0.04 2.06 (1.03-4.13)
   Present   60 (28)   47 (78) 13 (22) 0.03 0.49 (0.24-0.98)
Tobacco
   Non smoker 119 (55)   85 (71) 34 (29) NS
   Past smoker 11 (5)     9 (82)   2 (18) NS
   Current smoker (all)   87 (40)   53 (61) 36 (39) 0.03 1.88 (1.08-3.35)
   Current smoker 0.5 p/d   48 (22)   26 (54) 22 (46) 0.03 5.2 (1.1-4.12)
   Current smoker > 1.0 p/d   39 (18)   27 (69) 12 (31) NS
Age
   Mean age               45.3                  46.57                 42.78 0.06
Sex
   Male   97 (45)   64 (66) 33 (34) NS
   Female 120 (55)   83 (69) 37 (31) NS
Body Mass Index
   Mean BMI               29.8                  30.6                28.1 NS
P value indicates results of the comparison of H. pylori positive patients and H. pylori negative patients. OR: Odds ratio; BMI: Body mass index; NS: Not sig-
nificant; H. pylori: Helicobacter pylori.
Table 4  Relationship between reflux and Barrett’s esophagus, hiatus hernia, tobacco use, sex, age and body mass index  n  (%)
Total Reflux P  value
Grade 0 Grade 1 Grade 2
No. of patients               217             59              17 141
Short segment Barrett’s   9 (4)   1 (11)                0     8 (89) 0.010
Long segment Barrett’s 19 (9) 1 (5)   1 (5)   17 (90) 0.010
Normal gastroesophageal junction 189 (87) 59 (31) 16 (9) 114 (60) 0.002
Hiatus hernia
   Absent 157 (72) 49 (31) 13 (8)   94 (61) 0.060
   Present   60 (28) 10 (17)   4 (7)   46 (76) NS
Tobacco
   Non smoker 119 (55) 32 (27)   13 (11)   74 (62) NS
   Past smoker 11 (5)   1 (10)     1 (10)     9 (80) NS
   Current smoker all   87 (40) 26 (29)   11 (13)   51 (48) NS
   Current smoker 0.5 p/d   48 (22) 14 (29)     7 (15)   27 (56) NS
   Current smoker > 1.0 p/d   39 (18) 12 (30)   3 (8)   24 (62) NS
Sex
   Male   97 (45) 22 (23)   6 (6)   69 (71) NS
   Female 120 (55) 37 (31) 11 (9)   72 (60) NS
Age
   Mean age                 45.3             42              45.2 46.8 0.080
Body Mass Index
   Mean BMI                 29.8             27.9              33.1 30.2 0.080
BMI: Body mass index; NS: Not significant.
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point at which the tubular esophagus joins the saccular 
stomach[24-26]. 
In our study, IMC was histologically found in 92 pa-
tients (42%). Whereas H. pylori was present in 70 patients 
(32%), the distribution of  H. pylori was similar in patients 
with or without IMC, suggesting that no significant re-
lationship between H. pylori and IMC exists. We found 
that H. pylori was strongly associated with the presence 
of  carditis without IMC, as previously reported. Indeed, 
Sotoudeh et al[3] found a significant relationship between 
carditis and H. pylori infection in an Iranian cohort of  
patients in which the infection rate was as high as 85% 
whereas our infection rate was close to 32%. In contrast 
to our study, Goldblum et al[10] found that not only was 
H. pylori associated with carditis but also with IMC. In 
our series there was a strong correlation between the 
presence of  H. pylori and acute or chronic inflammation 
in biopsies taken at different sites of  the stomach. This 
finding is consistent with several other eastern observa-
tions showing that carditis is more associated with H. pylori 
infection than with GERD. In our study, GERD was 
present in 141 patients (65%) and was not found to be 
significantly associated with IMC, whereas GERD was 
strongly associated with acute and chronic inflamma-
tion of  the gastroesophageal junction, a feature already 
reported by others[27,28]. Voutilainen et al[14] reported that 
there are two dissimilar types of  chronic inflammation of  
the gastric cardiac mucosa that seem to occur: one exist-
ing in conjunction with chronic H. pylori infection and the 
other with normal stomach and erosive GERD. Patients 
with IMC also had significantly higher rates of  metaplasia 
of  other gastric areas. Therefore finding antral or cor-
poreal metaplasia should alert the gastroenterologist to 
redo a biopsy of  the cardia in a subsequent endoscopy. 
The absence of  any correlation between the presence of  
IMC and Barrett’s esophagus might indicate that IMC is 
a distinct entity from Barrett’s esophagus as proposed by 
Golblum[16]. Similar inflammation and mucosal alteration 
in the antrum and the corpus should be regarded as a po-
tential sign of  predisposition to IMC. We found that the 
risk of  having IMC was associated with increasing age 
since 70.5% of  patients with IMC were > 40 years old, 
a feature also reported by McNamara et al[29] in a cohort 
of  36 patients with IMC. Among other factors associated 
with IMC, tobacco use was found to be strongly associ-
ated with the development of  IMC and 68% of  patients 
with IMC were smokers, data never reported before, to 
our knowledge. Indeed, Koizumi et al[5] reported an in-
creased risk of  IMC of  1.84 (1.39-2.43 95% CI) only for 
antral cancer in current smokers compared with subjects 
Table 5  Factors associated with intestinal metaplasia of the cardia  n  (%)
Total Intestinal metaplasia P  value OR (95% CI)
Absent Present
No. of patients (%)              217 125 (58) 92 (42)
Indications for endoscopy
   GERD1 141 (65) 106 (75) 35 (25) NS
   Epigastric pain1   62 (29)   41 (66) 21 (34) NS
   Gastric bypass   48 (22)   30 (63) 18 (37) NS
Results of endoscopy
   Normal   79 (36)   41 (52) 38 (48) NS
   GERD   26 (12)   10 (38) 16 (62) 0.060
   Hiatus hernia   60 (28)   26 (43) 34 (57) NS
   Barrett's esophagus   28 (13)   13 (46) 15 (54) NS
   Other   29 (13)   17 (59) 12 (41) NS
H. pylori
   Positive   70 (32)   34 (49) 36 (51)
   Negative 147 (68)   91 (62) 56 (28) 0.060
Reflux = 0   59 (27)   33 (56) 26 (44)
Reflux = 1 17 (8)   15 (88)   2 (12)
Reflux = 22 141 (65)   77 (55) 64 (45) 0.060
BMI 29.8 ± 10.6              31.61              27.33
Age 45.3 ± 15.3              43.29              50.68
Sex
   Male   97 (45)   55 (57) 42 (43) NS
   Female 120 (55)   70 (58) 50 (42) NS
Tobacco use
   Non smoker              119               89             30
   Past smoker                11                 8               3 0.500     0.6 (0.13-1.9)
   Current smoker all                87               28             59 0.001   6.19 (3.4-11.2)
   Current smoker 0.5 p/d                48               14             32 0.001 4.23 (2.1-8.5)
   Current smoker > 1.0 p/d                39               12             27 0.010 4.33 (2.1-9.1)
Antrum metaplasia                19                 5             14 0.010     4.31 (1.49-12.4)
Fundus metaplasia                  9                 1               8 0.001     11.8 (1.45-96.1)
P value indicates results of the comparison of patients with or without intestinal metaplasia of the cardia. 1patients may have more than one reason for en-
doscopy; 2data are missing. GERD: Gastroesophageal reflux disease; OR: Odds ratio; BMI: Body mass index; NS: Not significant; H. pylori: Helicobacter pylori. 
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who had never smoked. BMI was surprisingly found to 
be a protective factor: the greater the BMI the less it con-
tributed to the risk of  IMC. This specific point should be 
balanced by the fact that the majority of  our population 
was under the threshold of  obesity. This finding could 
seem controversial against the current literature that sug-
gests a link between obesity, GERD and carcinoma[30]. 
Although a real prospective study design is needed to 
assess a prediction, our statistician has tried to find the 
best fitting model to describe the relationship between 
the presence of  IMC and various predisposing factors. 
The final mathematical equation provided an evaluation 
(and not the risk) of  a subject’s likelihood of  having IMC. 
In the current study, the presence of  IMC could be pre-
dicted by age, smoking habit and low or normal BMI. The 
evaluation showed no association with GERD. H. pylori had 
only a borderline significance (P = 0.07) if  any. Neverthe-
less, this point must be emphasized because recent stud-
ies have found two types of  cardia cancer, one linked to 
H. pylori-associated atrophic gastritis, and the other asso-
ciated with nonatrophic gastritis, resembling esophageal 
adenocarcinoma[7]. 
Although our study was not prospective, it gives 
results at a particular point in time, and points out the 
greater need for endoscopic surveillance of  gastric car-
dia mucosal changes in individuals aged 40 and over. 
Regarding the epidemiology of  adenocarcinoma of  the 
esophagus and gastroesophageal junction, the patterns 
of  each disease are sufficiently alike to implicate shared 
risk factors or even to represent a single neoplastic entity. 
Although studies at the molecular level have produced 
conflicting results, many have demonstrated the similarity 
between adenocarcinomas of  the cardia and esophagus. 
Most important is the evidence that the overall survival 
is similar in patients with gastroesophageal junction and 
esophageal adenocarcinoma. 
In summary, this study indicates that chronically in-
flamed gastric mucosa in the cardia area can be replaced 
by intestinal metaplasia, a finding which has been shown 
to precede the development of  cardia cancer. Whereas 
esophageal adenocarcinomas are strongly associated with 
GERD and obesity and are inversely associated with 
H. pylori, we suggest that IMC is not convincingly associ-
ated with GERD, is inversely correlated with BMI and has 
a dubious association with the presence of  H. pylori, but 
is associated with increased age and a smoking habit. A 
prospective study aimed at evaluating the true incidence 
and natural history of  IMC is therefore clearly needed.
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The study indicates there is a greater need for endoscopic surveillance of gas-
tric cardia mucosal changes in individuals aged 40 and over.
Terminology
Intestinal metaplasia of the cardia represents a mucosal change of the gastric 
cardia that is secondary to chronic inflammation and that can be considered as 
a potential precursor of cancer.
Peer review
The paper is a well-written manuscript with an important topic in clinical epide-
miology. The authors tried to study the risk factors for intestinal metaplasia of 
the cardia. In addition they compared these factors with the epidemiological cri-
teria of patients with Barrett’s esophagus. The results show that Barrett mucosa 
and IMC differed according their etiological factors. 
REFERENCES
1 Conio M, Filiberti R, Blanchi S, Giacosa A. Carditis, intes-
tinal metaplasia and adenocarcinoma of oesophagogastric 
junction. Eur J Cancer Prev 2001; 10: 483-487
2 Fuchs F, Poirier B, Leparc-Goffart I, Buchheit KH. Collabor-
ative study for the establishment of the Ph. Eur. BRP batch 
1 for anti-vaccinia immunoglobulin. Pharmeuropa Bio 2005; 
2005: 13-18
3 Sotoudeh M, Derakhshan MH, Abedi-Ardakani B, No-
uraie M, Yazdanbod A, Tavangar SM, Mikaeli J, Merat S, 
Malekzadeh R. Critical role of Helicobacter pylori in the 
pattern of gastritis and carditis in residents of an area with 
high prevalence of gastric cardia cancer. Dig Dis Sci 2008; 
53: 27-33
4 Fitzsimmons D, Osmond C, George S, Johnson CD. Trends 
in stomach and pancreatic cancer incidence and mortality in 
England and Wales, 1951-2000. Br J Surg 2007; 94: 1162-1171
5 Koizumi Y, Tsubono Y, Nakaya N, Kuriyama S, Shibuya D, 
Matsuoka H, Tsuji I. Cigarette smoking and the risk of gas-
tric cancer: a pooled analysis of two prospective studies in 
Japan. Int J Cancer 2004; 112: 1049-1055
6 McColl KE. Cancer of the gastric cardia. Best Pract Res Clin 
Gastroenterol 2006; 20: 687-696
7 Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, 
Aase S, Jellum E, McColl KE. Two distinct aetiologies of car-
dia cancer; evidence from premorbid serological markers of 
gastric atrophy and Helicobacter pylori status. Gut 2007; 56: 
918-925
8 Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres 
T, Pinto I, Santos-Pereira R, Lunet N. Smoking and gastric 
cancer: systematic review and meta-analysis of cohort stud-
ies. Cancer Causes Control 2008; 19: 689-701 
9 Axon AT. Relationship between Helicobacter pylori gas-
tritis, gastric cancer and gastric acid secretion. Adv Med Sci 
2007; 52: 55-60 
10 Goldblum JR. Inflammation and intestinal metaplasia of 
the gastric cardia: Helicobacter pylori, gastroesophageal re-
flux disease, or both. Dig Dis 2000; 18: 14-19 
11 Hjartåker A, Langseth H, Weiderpass E. Obesity and diabe-
tes epidemics: cancer repercussions. Adv Exp Med Biol 2008; 
630: 72-93 
12 Festi D, Scaioli E, Baldi F, Vestito A, Pasqui F, Di Biase AR, 
Colecchia A. Body weight, lifestyle, dietary habits and gas-
troesophageal reflux disease. World J Gastroenterol 2009; 15: 
1690-1701 
13 Corley DA, Kubo A, Zhao W. Abdominal obesity and the 
risk of esophageal and gastric cardia carcinomas. Cancer 
 COMMENTS
Felley C et al . Risk factors for cardia intestinal metaplasia
2083 May 7, 2012|Volume 18|Issue 17|WJG|www.wjgnet.com
Epidemiol Biomarkers Prev 2008; 17: 352-358
14 Voutilainen M, Färkkilä M, Mecklin JP, Juhola M, Sipponen 
P. Chronic inflammation at the gastroesophageal junction 
(carditis) appears to be a specific finding related to Helico-
bacter pylori infection and gastroesophageal reflux disease. 
The Central Finland Endoscopy Study Group. Am J Gastro-
enterol 1999; 94: 3175-3180
15 Voutilainen M, Sipponen P. Inflammation in the cardia. 
Curr Gastroenterol Rep 2001; 3: 215-218
16 Goldblum JR, Vicari JJ, Falk GW, Rice TW, Peek RM, Eas-
ley K, Richter JE. Inflammation and intestinal metaplasia of 
the gastric cardia: the role of gastroesophageal reflux and H. 
pylori infection. Gastroenterology 1998; 114: 633-639
17 Felley C, Perneger TV, Goulet I, Rouillard C, Azar-Pey N, 
Dorta G, Hadengue A, Frossard JL. Combined written and 
oral information prior to gastrointestinal endoscopy com-
pared with oral information alone: a randomized trial. BMC 
Gastroenterol 2008; 8: 22
18 Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The 
Montreal definition and classification of gastroesophageal 
reflux disease: a global evidence-based consensus. Am J Gas-
troenterol 2006; 101: 1900-120; quiz 1943
19 Kahrilas PJ, Kim HC, Pandolfino JE. Approaches to the 
diagnosis and grading of hiatal hernia. Best Pract Res Clin 
Gastroenterol 2008; 22: 601-616
20 Dixon MF, Genta RM, Yardley JH, Correa P. Classification 
and grading of gastritis. The updated Sydney System. In-
ternational Workshop on the Histopathology of Gastritis, 
Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181
21 Filipe MI, Muñoz N, Matko I, Kato I, Pompe-Kirn V, Jut-
ersek A, Teuchmann S, Benz M, Prijon T. Intestinal meta-
plasia types and the risk of gastric cancer: a cohort study in 
Slovenia. Int J Cancer 1994; 57: 324-329
22 Wang KK, Sampliner RE. Updated guidelines 2008 for the 
diagnosis, surveillance and therapy of Barrett’s esophagus. 
Am J Gastroenterol 2008; 103: 788-797
23 Bobbioni-Harsch E, Huber O, Morel P, Chassot G, Lehm-
ann T, Volery M, Chliamovitch E, Muggler C, Golay A. Fac-
tors influencing energy intake and body weight loss after 
gastric bypass. Eur J Clin Nutr 2002; 56: 551-556
24 Odze RD. Pathology of the gastroesophageal junction. 
Semin Diagn Pathol 2005; 22: 256-265
25 Riddell RH. The biopsy diagnosis of gastroesophageal 
reflux disease, “carditis,” and Barrett’s esophagus, and se-
quelae of therapy. Am J Surg Pathol 1996; 20 Suppl 1: S31-S50 
26 Petersson F, Franzén LE, Borch K. Characterization of the 
gastric cardia in volunteers from the general population. 
Type of mucosa, Helicobacter pylori infection, inflamma-
tion, mucosal proliferative activity, p53 and p21 expression, 
and relations to gastritis. Dig Dis Sci 2010; 55: 46-53
27 Pieramico O, Zanetti MV. Relationship between intestinal 
metaplasia of the gastro-oesophageal junction, Helicobacter 
pylori infection and gastro-oesophageal reflux disease: a 
prospective study. Dig Liver Dis 2000; 32: 567-572
28 Csendes A, Smok G, Quiroz J, Burdiles P, Rojas J, Castro C, 
Henríquez A. Clinical, endoscopic, and functional studies 
in 408 patients with Barrett’s esophagus, compared to 174 
cases of intestinal metaplasia of the cardia. Am J Gastroen-
terol 2002; 97: 554-560
29 McNamara D, Buckley M, Crotty P, Hall W, O’Sullivan 
M, O’Morain C. Carditis: all Helicobacter pylori or is there 
a role for gastro-oesophageal reflux? Scand J Gastroenterol 
2002; 37: 772-777
30 Balbuena L, Casson AG. Physical activity, obesity and 
risk for esophageal adenocarcinoma. Future Oncol 2009; 5: 
1051-1063
S- Editor  Gou SX    L- Editor  Cant MR    E- Editor  Zheng XM
Felley C et al . Risk factors for cardia intestinal metaplasia
